JPWO2009116636A1 - Mineral fortified soy protein solution - Google Patents
Mineral fortified soy protein solution Download PDFInfo
- Publication number
- JPWO2009116636A1 JPWO2009116636A1 JP2010503933A JP2010503933A JPWO2009116636A1 JP WO2009116636 A1 JPWO2009116636 A1 JP WO2009116636A1 JP 2010503933 A JP2010503933 A JP 2010503933A JP 2010503933 A JP2010503933 A JP 2010503933A JP WO2009116636 A1 JPWO2009116636 A1 JP WO2009116636A1
- Authority
- JP
- Japan
- Prior art keywords
- soy protein
- soy
- mineral
- calcium
- protein solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010073771 Soybean Proteins Proteins 0.000 title claims abstract description 124
- 229940001941 soy protein Drugs 0.000 title claims abstract description 111
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 33
- 239000011707 mineral Substances 0.000 title claims abstract description 33
- 239000012460 protein solution Substances 0.000 title claims description 47
- 235000013322 soy milk Nutrition 0.000 claims abstract description 47
- 239000000463 material Substances 0.000 claims abstract description 39
- 108010083391 glycinin Proteins 0.000 claims abstract description 34
- 229940043430 calcium compound Drugs 0.000 claims abstract description 32
- 150000001674 calcium compounds Chemical class 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000002738 chelating agent Substances 0.000 claims abstract description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 37
- 239000011575 calcium Substances 0.000 claims description 37
- 229910052791 calcium Inorganic materials 0.000 claims description 37
- 235000010755 mineral Nutrition 0.000 claims description 31
- 235000010469 Glycine max Nutrition 0.000 claims description 22
- 244000068988 Glycine max Species 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- 235000019710 soybean protein Nutrition 0.000 claims description 13
- 235000019750 Crude protein Nutrition 0.000 claims description 11
- -1 alkali metal salt Chemical class 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 235000021056 liquid food Nutrition 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 206010065713 Gastric Fistula Diseases 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 abstract description 16
- 238000004220 aggregation Methods 0.000 abstract description 15
- 239000000796 flavoring agent Substances 0.000 abstract description 10
- 235000019634 flavors Nutrition 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 6
- 235000021568 protein beverage Nutrition 0.000 abstract description 4
- 229960005069 calcium Drugs 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 235000013336 milk Nutrition 0.000 description 13
- 239000008267 milk Substances 0.000 description 13
- 210000004080 milk Anatomy 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 9
- 239000001527 calcium lactate Substances 0.000 description 9
- 235000011086 calcium lactate Nutrition 0.000 description 9
- 229960002401 calcium lactate Drugs 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 239000001509 sodium citrate Substances 0.000 description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 6
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical group [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 101710196266 Protein 4.1 Proteins 0.000 description 1
- 102100031952 Protein 4.1 Human genes 0.000 description 1
- 101710196213 Protein 4.7 Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical class [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- PVGBHEUCHKGFQP-UHFFFAOYSA-N sodium;n-[5-amino-2-(4-aminophenyl)sulfonylphenyl]sulfonylacetamide Chemical compound [Na+].CC(=O)NS(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 PVGBHEUCHKGFQP-UHFFFAOYSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本発明は、カルシウム化合物を添加する際に生じる凝集を抑制するために、前処理等の煩雑な工程を必要とせず、かつ風味良好なミネラルを強化した豆乳などの大豆蛋白飲料の提供を課題とする。大豆蛋白質の主成分の一つであるグリシニンの存在比を低減した大豆蛋白素材を原料として使用すると、大豆蛋白質と反応性の高い水易溶性のカルシウム化合物が添加される場合であっても、一般的な大豆蛋白素材を使用するよりも高濃度のカルシウム化合物の添加に対して安定であること、さらにはキレート剤を添加することによって、より高濃度のカルシウム化合物を添加できるという知見を得ることができ、上記課題を解決するに到った。It is an object of the present invention to provide a soy protein beverage such as soy milk that does not require a complicated process such as pretreatment and has a flavour-enriched mineral in order to suppress aggregation that occurs when a calcium compound is added. To do. Using a soy protein material with a reduced abundance ratio of glycinin, which is one of the main components of soy protein, as a raw material, To obtain the knowledge that it is more stable against the addition of high concentration calcium compounds than using a typical soy protein material, and that a higher concentration of calcium compounds can be added by adding a chelating agent. It was possible to solve the above problems.
Description
本発明は、大豆蛋白素材とミネラルとしてカルシウム化合物を強化し、栄養価に優れ、かつ保存中に凝集や沈殿が生じにくい安定な品質の大豆蛋白溶液に関する。 The present invention relates to a soy protein solution having a stable quality in which a calcium compound is fortified as a soy protein material and a mineral, is excellent in nutritional value, and hardly causes aggregation or precipitation during storage.
大豆は、良質な蛋白質である大豆蛋白質を多く含み、古くから優れた蛋白質の供給源として利用されている。例えば豆乳は大豆に含まれる良質なタンパク質、イソフラボン、レシチン、サポニン、リノール酸などに有用成分が含まれているため、そのままあるいは風味付けをして健康飲料として市場に広がっている。豆乳の他に大豆蛋白質を含む大豆蛋白素材としては、大豆粉、脱脂大豆粉、濃縮大豆蛋白、そして分離大豆蛋白などがあり、それぞれ目的に応じて食品分野で使用されている。 Soy contains a lot of soy protein, which is a high-quality protein, and has long been used as a source of excellent protein. For example, soy milk contains useful components such as high-quality protein, isoflavone, lecithin, saponin, linoleic acid, etc. contained in soybeans, and has spread to the market as a healthy drink as it is or with flavor. In addition to soy milk, soy protein materials containing soy protein include soy flour, defatted soy flour, concentrated soy protein, and isolated soy protein, each of which is used in the food field depending on the purpose.
しかし大豆蛋白素材は、牛乳と成分を比較した場合、カルシウムの含量が低い。例えば牛乳は100gあたり約100mg含まれるが、豆乳の場合には約15mg程度しか含まれていない。日本の食生活では1日に必要なカルシウム量を摂取することが困難とされており、近年カルシウム不足が引き起こす疾患が問題となっている。以上から、カルシウムを強化した大豆蛋白飲料は、栄養バランス面において非常に優れた飲料と考えられる。 However, soy protein materials have a low calcium content when compared to milk and ingredients. For example, although about 100 mg of milk is contained per 100 g, soy milk contains only about 15 mg. In Japan's diet, it is considered difficult to consume the amount of calcium necessary for one day, and in recent years, diseases caused by calcium deficiency have become a problem. From the above, the soy protein beverage fortified with calcium is considered to be a very excellent beverage in terms of nutritional balance.
しかし、カルシウム塩は豆腐の凝固剤として一般的に用いられている通り、高濃度のカルシウム塩を添加すると豆乳は凝固してしまう。この問題点を解決するために、pHを調整して蛋白質を変性させる方法(特許文献1:特開昭52−90662号公報)、グリセリンまたはポリプロピレングリコール存在下で、豆乳にカルシウム化合物を添加する方法(特許文献2:特開昭58−13358号公報)、豆乳を蛋白分解酵素で加水分解し、低分子化した後カルシウム溶液を添加する方法(特許文献3:特開平6−7105号公報)、乳酸菌を用いて発酵して蛋白質を変性させる方法(特許文献4:特開昭60−2153号公報)などが開示されている。 However, as calcium salt is commonly used as a coagulant for tofu, soy milk coagulates when a high concentration of calcium salt is added. In order to solve this problem, a method of modifying a protein by adjusting pH (Patent Document 1: Japanese Patent Laid-Open No. 52-90662), a method of adding a calcium compound to soy milk in the presence of glycerin or polypropylene glycol (Patent Document 2: Japanese Patent Laid-Open No. 58-13358), a method of hydrolyzing soymilk with a proteolytic enzyme and reducing the molecular weight, and then adding a calcium solution (Patent Document 3: Japanese Patent Laid-Open No. 6-7105), A method of denaturing proteins by fermentation using lactic acid bacteria (Patent Document 4: Japanese Patent Laid-Open No. 60-2153) is disclosed.
しかし、これらの方法は、豆乳にカルシウムを添加する前にpH調整や酵素処理等の前処理が必要となるため製品の製造に煩雑な工程が必要である。 However, since these methods require pretreatment such as pH adjustment and enzyme treatment before adding calcium to soymilk, complicated steps are required for production of the product.
一方、これらのような前処理を必要としない方法として、豆乳にカルシウム塩とクエン酸塩を添加する方法(特許文献5:特開2004−208566号公報)、豆乳にリンゴ酸カルシウムを添加してカルシウム分を強化する方法(特許文献6:特開昭60−47635号公報)が開示されている。 On the other hand, as a method that does not require such pretreatment, a method of adding calcium salt and citrate to soy milk (Patent Document 5: Japanese Patent Application Laid-Open No. 2004-208566), adding calcium malate to soy milk A method for strengthening the calcium content (Patent Document 6: Japanese Patent Laid-Open No. 60-47635) is disclosed.
しかし、特許文献5の場合、牛乳レベルにカルシウム量を強化するためにはクエン酸塩を高濃度に添加しなくてはならないため、豆乳の風味に少なからず影響を与えてしまう。また、特許文献6の場合、添加できるカルシウム量が30mgを上限とするため、牛乳レベルのカルシウムを含む豆乳の製造は不可能である。 However, in the case of Patent Document 5, in order to enhance the amount of calcium to the milk level, citrate must be added at a high concentration, which has a considerable influence on the flavor of soy milk. Further, in the case of Patent Document 6, since the upper limit of the amount of calcium that can be added is 30 mg, it is impossible to produce soymilk containing milk at the milk level.
(参考文献)
本発明は、カルシウム化合物を添加する際に生じる凝集を抑制するために、前処理等の煩雑な工程を必要とせず、かつ風味良好なミネラル強化大豆蛋白溶液の提供を課題とする。 An object of the present invention is to provide a mineral-enriched soy protein solution that does not require complicated steps such as pretreatment and suppresses aggregation that occurs when a calcium compound is added, and that has a good flavor.
本出願人はグリシニンを低減し、代わりにβ−コングリシニンの含量を増やした大豆蛋白素材を使用し、大豆蛋白飲料を得ることを先に開示している(特開2002−262838号公報)。この飲料にさらにカルシウムを添加する際、通常はカルシウム剤として大豆蛋白質との反応による凝集をなるべく避けるべく、特開2005−65542号公報などを参照して第三リン酸カルシウムなどの水難溶性カルシウムを添加しようとするであろう。このような水難溶性カルシウムの添加は、それ自体を水に分散させて保存中の沈殿を防止するために、別途特別な処理を要する。
そこで本発明者らは、カルシウム添加時の凝集抑制のために種々の添加剤を組み合わせたり前処理を行うという思想にこだわることなく、豆乳などの大豆蛋白素材に含まれる蛋白質の構成に着目し、この構成成分の存在比が変わることで課題を解決できないか鋭意研究を行った。
その結果、大豆蛋白質の主成分の一つであるグリシニンの存在比を低減した大豆蛋白素材を原料として使用すると、大豆蛋白質と反応性の高い水易溶性のカルシウム化合物が添加される場合であっても、一般的な大豆蛋白素材を使用するよりも高濃度のカルシウム化合物の添加に対して安定であること、さらにはキレート剤を添加することによって、より高濃度のカルシウム化合物を添加できるという知見を得ることができ、上記課題を解決するに到った。The present applicant has previously disclosed obtaining a soy protein beverage by using a soy protein material in which the content of β-conglycinin is increased instead of glycinin (Japanese Patent Laid-Open No. 2002-262838). When adding further calcium to this beverage, usually add poorly water-soluble calcium such as tricalcium phosphate with reference to JP-A-2005-65542 as much as possible to avoid aggregation due to reaction with soy protein as a calcium agent. Would be. Such addition of poorly water-soluble calcium requires a special treatment in order to disperse itself in water and prevent precipitation during storage.
Therefore, the present inventors pay attention to the composition of the protein contained in the soy protein material such as soy milk, without sticking to the idea of combining various pre-treatments or pretreatment for aggregation suppression at the time of calcium addition, We conducted intensive research to see if the problem could be solved by changing the abundance ratio of these components.
As a result, when a soy protein material with a reduced ratio of glycinin, one of the main components of soy protein, is used as a raw material, a readily water-soluble calcium compound that is highly reactive with soy protein is added. However, the knowledge that it is more stable against the addition of high concentration calcium compounds than using general soybean protein materials, and that a higher concentration of calcium compounds can be added by adding a chelating agent. It was possible to obtain the above problem.
即ち、本発明は、
1.水易溶性のカルシウム化合物と、大豆蛋白質中のグリシニン含量が低減された大豆蛋白素材が配合された大豆蛋白溶液であって、該大豆蛋白素材を粗蛋白質量として0.5〜20質量%含み、溶液中のカルシウム含量が100g当たり40mg以上であることを特徴とするミネラル強化大豆蛋白溶液、
2.キレート剤がさらに配合されている前記1.記載のミネラル強化大豆蛋白溶液、
3.キレート剤がカルボン酸のアルカリ金属塩である前記2.記載のミネラル強化大豆蛋白溶液、
4.pH向上剤がさらに配合されている前記2.記載のミネラル強化大豆蛋白溶液、
5.pH向上剤が炭酸水素ナトリウムである前記4.記載のミネラル強化大豆蛋白溶液、
6.大豆蛋白素材中のグリシニン含量が、大豆蛋白質あたり30質量%未満である前記1.記載のミネラル強化大豆蛋白溶液、
7.大豆蛋白素材が、大豆からグリシニンの一部もしくは全部を除去して調製されるか、又はグリシニンの一部もしくは全部が欠失した大豆から調製されるものである、前記1.記載のミネラル強化大豆蛋白溶液、
8.大豆蛋白素材が豆乳、分離大豆蛋白、濃縮大豆蛋白又は大豆粉である前記1.記載のミネラル強化大豆蛋白溶液、
9.大豆蛋白溶液が液状食品、飲料、濃厚流動食又は胃ろう用栄養液である前記1.記載のミネラル強化大豆蛋白溶液、
10.カルシウム化合物と大豆蛋白素材が配合される大豆蛋白溶液の製造において、カルシウム化合物として水易溶性カルシウム化合物を使用し、大豆蛋白素材として、大豆蛋白質中のグリシニン含量が低減された大豆蛋白素材を使用することを特徴とする、大豆蛋白溶液のミネラル強化方法、
を提供するものである。That is, the present invention
1. A soy protein solution containing a readily water-soluble calcium compound and a soy protein material having a reduced glycinin content in soy protein, comprising 0.5 to 20% by mass of the soy protein material as a crude protein mass, A mineral-enriched soy protein solution, wherein the calcium content in the solution is 40 mg or more per 100 g;
2. 1. The chelating agent is further blended. Mineral-enhanced soy protein solution as described,
3. 2. The chelating agent is an alkali metal salt of carboxylic acid. Mineral-enhanced soy protein solution as described,
4). 2. The pH improver is further blended. Mineral-enhanced soy protein solution as described,
5. 4. The pH improver is sodium bicarbonate. Mineral-enhanced soy protein solution as described,
6). 1. The glycinin content in the soy protein material is less than 30% by mass per soy protein. Mineral-enhanced soy protein solution as described,
7). 1. The soybean protein material is prepared by removing part or all of glycinin from soybean, or prepared from soybean lacking part or all of glycinin. Mineral-enhanced soy protein solution as described,
8). 1. The soy protein material is soy milk, separated soy protein, concentrated soy protein or soy flour. Mineral-enhanced soy protein solution as described,
9. 1. The soy protein solution is a liquid food, beverage, concentrated liquid food or gastric fistula nutrient solution. Mineral-enhanced soy protein solution as described,
10. In the production of a soy protein solution containing a calcium compound and a soy protein material, a water-soluble calcium compound is used as the calcium compound, and a soy protein material in which the glycinin content in the soy protein is reduced is used as the soy protein material. A method for fortifying minerals of a soy protein solution,
Is to provide.
本発明により、水易溶性カルシウム化合物が多く配合されていても製造中や保存中に凝集が発生しにくく、安定なミネラル強化大豆蛋白溶液を得ることが可能である。 According to the present invention, it is possible to obtain a stable mineral-enriched soy protein solution that is less likely to aggregate during production or storage even when a large amount of readily water-soluble calcium compound is blended.
本発明のミネラル強化大豆蛋白溶液は、水易溶性のカルシウム化合物と、大豆蛋白質中のグリシニン含量が低減された大豆蛋白素材が配合された大豆蛋白溶液であって、該大豆蛋白素材を粗蛋白質量として0.5〜20質量%含み、溶液中のカルシウム含量が100g当たり40mg以上であることを特徴とする。以下、本発明の技術的事項について説明する。以下の説明において特に断らない限り「%」は「質量%」、「部」は「質量部」を意味する。 The mineral-enriched soy protein solution of the present invention is a soy protein solution in which a readily water-soluble calcium compound and a soy protein material having a reduced glycinin content in soy protein are blended, and the soy protein material has a crude protein mass. As 0.5 to 20% by mass, and the calcium content in the solution is 40 mg or more per 100 g. The technical items of the present invention will be described below. In the following description, “%” means “% by mass” and “parts” means “parts by mass” unless otherwise specified.
(大豆蛋白溶液)
本発明において、ミネラル強化大豆蛋白溶液はカルシウム化合物と大豆蛋白素材が配合された溶液であり、その用途はスープやシチューなどの液状食品、大豆蛋白飲料や豆乳飲料などの飲料として利用できる他、濃厚流動食などの特殊な用途にも利用できる。また医療用途として、胃ろう(PEG:Percutaneous Endoscopic Gastrostomy)用の栄養液としても利用することが可能である。
またこの大豆蛋白溶液をさらに粉末状に加工して粉末製品としたり、凍結させて冷凍製品とするなどして種々の加工形態に変えることは自由である。(Soy protein solution)
In the present invention, the mineral-enriched soy protein solution is a solution in which a calcium compound and a soy protein material are blended, and its use can be used as a liquid food such as soup and stew, and a beverage such as a soy protein beverage and a soy milk beverage. It can also be used for special purposes such as liquid food. It can also be used as a nutrient solution for gastric fistula (PEG: Percutaneous Endoscopic Gastrostomy) for medical purposes.
Further, the soy protein solution can be further processed into a powder form to obtain a powder product, or can be frozen to obtain a frozen product.
(大豆蛋白素材)
本発明のミネラル強化大豆蛋白溶液に配合される大豆蛋白素材としては、大豆粉(全脂、脱脂等を問わない)、豆乳(全脂、脱脂等を問わない)、分離大豆蛋白、濃縮大豆蛋白などのいずれをも選択することができる。該溶液中に配合する大豆蛋白素材の量は製造する溶液の製品コンセプト、風味、物性等を考慮して当業者が自由に設定できるが、通常は該溶液あたりの粗蛋白質量として、0.5〜20%、好ましくは0.7〜10%、より好ましくは1〜8%とすることができる。
本発明では上記の大豆蛋白素材の大豆蛋白質中のグリシニン含量が低減されていることが重要である。グリシニンは大豆の主要な貯蔵蛋白質であるグロブリンの一種であり、11S蛋白質とも称される。かかる大豆蛋白素材を使用することによってカルシウム化合物を安定な状態で多量に添加することが可能である。特に、グリシニン含量が大豆蛋白質あたり30%未満であることが好ましく、25%未満がより好ましく、15%以下がさらに好ましく、グリシニンが欠失して実質的に0%であるのが最も好ましい。(Soy protein material)
The soy protein material blended in the mineral-enriched soy protein solution of the present invention includes soy flour (whether full fat, defatted, etc.), soy milk (whether full fat, defatted, etc.), isolated soy protein, concentrated soy protein Any of these can be selected. The amount of the soy protein material to be blended in the solution can be freely set by those skilled in the art in consideration of the product concept, flavor, physical properties, etc. of the solution to be produced. Usually, the amount of crude protein per solution is 0.5%. -20%, preferably 0.7-10%, more preferably 1-8%.
In the present invention, it is important that the glycinin content in the soybean protein of the soybean protein material is reduced. Glycinin is a kind of globulin, which is the main storage protein of soybean, and is also referred to as 11S protein. By using such a soy protein material, a large amount of calcium compound can be added in a stable state. In particular, the glycinin content is preferably less than 30% per soy protein, more preferably less than 25%, even more preferably 15% or less, and most preferably glycinin is deleted and substantially 0%.
上記の特定の組成を有する大豆蛋白素材の調製方法は特に限定されるものではない。例えば、一般的な組成を有する大豆から調製した豆乳や分離大豆蛋白などからグリシニンの一部もしくは全部を分画除去する技術を用いて上記の組成に調製した大豆蛋白素材を使用することができる。グリシニンを分画除去する技術としては、従来公知のものを特に制限なく用いることができる。例えば、工業的規模での製造を可能とする国際公開WO2000/58492号、国際公開WO2002/028198号、国際公開WO2004/043160号、国際公開WO2006/129647号等に開示されるような公知の技術を利用することができる。また、予めグリシニンの一部もしくは全部を遺伝子操作や育種技術により欠失させた大豆か(Breeding Science, 46, 11, 1996など)から通常の方法により調製した大豆蛋白素材を使用することもできる。また上記のグリシニンの分画技術と欠失大豆を使用する技術の両方を用いて調製した素材を使用することもできる。 The method for preparing the soy protein material having the above specific composition is not particularly limited. For example, a soybean protein material prepared in the above-described composition using a technique for fractionating and removing glycinin from soy milk prepared from soybeans having a general composition, isolated soybean protein, or the like can be used. As a technique for fractionating and removing glycinin, a conventionally known technique can be used without particular limitation. For example, a known technique disclosed in International Publication WO2000 / 58492, International Publication WO2002 / 028198, International Publication WO2004 / 043160, International Publication WO2006 / 129647, or the like that enables manufacturing on an industrial scale. Can be used. It is also possible to use a soy protein material prepared by a conventional method from soybean (Breeding Science, 46, 11, 1996, etc.) from which part or all of glycinin has been deleted in advance by genetic manipulation or breeding technology. Moreover, the raw material prepared using both the said fractionation technique of glycinin and the technique using deletion soybean can also be used.
(カルシウム化合物)
本発明のミネラル強化大豆蛋白溶液に配合されるカルシウム化合物は、第三リン酸カルシウムのような水難溶性でなく、大豆蛋白質と容易に反応して通常であれば大豆蛋白質の凝集を引き起こす、水易溶性のタイプであることに意義がある。本発明において、水易溶性とは水に溶解しやすい性質をいい、より具体的には25℃における溶解度が水100gあたり0.1g以上のものをいう。
水易溶性である限り、カルシウム化合物は有機酸塩或いは無機酸塩の何れでもよい。化合物の例としては、酢酸塩、プロピオン酸塩、パントテン酸塩、乳酸塩、グルコン酸塩、グリセロリン酸塩、リンゴ酸塩、ステアロイル乳酸塩、フマル酸塩、コハク酸塩等の有機酸塩や、塩酸塩、第一リン酸塩、硫酸塩等の無機酸塩などが挙げられる。
ちなみに水難溶性のカルシウム化合物は、水に溶解しにくいか、全く溶解しない性質の化合物をいい、より具体的には25℃における溶解度が水100gに対して0.1g未満のものをいう。水難溶性の化合物の例としては、クエン酸塩、第二リン酸塩、第三リン酸塩、炭酸塩などが挙げられ、大豆蛋白質との反応性が低いものである。かかるカルシウム化合物の使用は大豆蛋白質との凝集反応を抑制するために効果的である反面、水に殆ど溶解しないため体内への吸収率が水溶性のカルシウム化合物よりも劣り、また溶解しないことによる沈殿が生じやすく、食感もざらついたものとなりやすい。
本発明のカルシウム化合物は、大豆蛋白溶液中のカルシウム含量(大豆蛋白素材に由来するカルシウムも含める)として、溶液100g当たり40mg以上、好ましくは50mg以上、より好ましくは60mg以上となるように添加することができる。そして最も好ましくは、牛乳レベルのカルシウム含量として80mg以上となるように添加することもできる。大豆蛋白素材のグリシニン含量の低減の程度や後述する有機酸のアルカリ塩の添加により、さらにその添加量を増量することが可能である。カルシウム含量を過度に高めすぎると許容範囲を超えて凝集が発生しやすくなるため、溶液100g当たり300mg以下、好ましくは200mg以下とするのが適当である。(Calcium compound)
The calcium compound blended in the mineral-enhanced soy protein solution of the present invention is not water-insoluble like tribasic calcium phosphate, but easily reacts with soy protein and usually causes aggregation of soy protein. It is meaningful to be a type. In the present invention, the readily water-soluble property means a property that is easily dissolved in water, and more specifically, one having a solubility at 25 ° C. of 0.1 g or more per 100 g of water.
As long as it is easily soluble in water, the calcium compound may be either an organic acid salt or an inorganic acid salt. Examples of compounds include organic acid salts such as acetate, propionate, pantothenate, lactate, gluconate, glycerophosphate, malate, stearoyl lactate, fumarate, succinate, Examples thereof include inorganic acid salts such as hydrochloride, primary phosphate and sulfate.
Incidentally, a poorly water-soluble calcium compound refers to a compound that is difficult to dissolve in water or does not dissolve at all, and more specifically, has a solubility at 25 ° C. of less than 0.1 g with respect to 100 g of water. Examples of the poorly water-soluble compound include citrate, diphosphate, tertiary phosphate, carbonate and the like, which are low in reactivity with soy protein. The use of such a calcium compound is effective for suppressing the agglutination reaction with soy protein, while it hardly dissolves in water, so its absorption rate into the body is inferior to that of a water-soluble calcium compound, and precipitation caused by not dissolving. It tends to occur and the texture tends to be rough.
The calcium compound of the present invention is added so that the calcium content in the soy protein solution (including calcium derived from the soy protein material) is 40 mg or more, preferably 50 mg or more, more preferably 60 mg or more per 100 g of the solution. Can do. Most preferably, it can be added so that the calcium content at the milk level is 80 mg or more. The amount of addition can be further increased by the degree of reduction of the glycinin content of the soybean protein material or the addition of an alkali salt of an organic acid described later. If the calcium content is excessively increased, aggregation is likely to occur beyond the allowable range. Therefore, the amount is preferably 300 mg or less, preferably 200 mg or less per 100 g of the solution.
(キレート剤)
本発明のミネラル強化大豆蛋白溶液にはさらにキレート剤が配合されることが好ましい。これによって豆乳の凝集をより効果的に抑制し、溶液中のカルシウム含量をより安定的に高めることができ、牛乳並みに溶液100g当たり100mgのカルシウムを配合することも容易となる。
キレート剤としてはクエン酸、リンゴ酸などのカルボキシル基を複数有するカルボン酸やフィチン酸などの有機酸、あるいはヘキサメタリン酸などの無機塩なども使用することができ、カルボン酸のアルカリ金属塩(ナトリウム塩又はカリウム塩)がより好ましい。特に、その中でもクエン酸ナトリウムを使用することが風味の観点で好ましい。
キレート剤の配合量はカルシウム化合物の添加量にもよるが、大豆蛋白溶液中に0.05%以上が好ましく、0.15%以上がより好ましい。ただし、あまりに添加量が多すぎると大豆蛋白溶液の風味に変化を及ぼしやすくなるため、0.5%未満が好ましく、0.45%以下がより好ましい。(Chelating agent)
It is preferable that a chelating agent is further blended in the mineral-enhanced soy protein solution of the present invention. As a result, aggregation of soy milk can be more effectively suppressed, the calcium content in the solution can be increased more stably, and 100 mg of calcium per 100 g of solution can be easily blended in the same manner as milk.
As chelating agents, carboxylic acids having a plurality of carboxyl groups such as citric acid and malic acid, organic acids such as phytic acid, and inorganic salts such as hexametaphosphoric acid can be used. Alkali metal salts of carboxylic acids (sodium salts) Or a potassium salt) is more preferable. In particular, it is preferable to use sodium citrate from the viewpoint of flavor.
The amount of the chelating agent depends on the amount of calcium compound added, but is preferably 0.05% or more, more preferably 0.15% or more in the soy protein solution. However, if the amount added is too large, the flavor of the soy protein solution tends to change, so less than 0.5% is preferable, and 0.45% or less is more preferable.
(pH向上剤)
本発明のミネラル強化大豆蛋白溶液には、さらにpH向上剤(pHをアルカリ性側へシフトさせるpH調整剤)が配合されることが好ましい。これによってキレート剤の配合量を減らしつつ、凝集のない安定な溶液を得ることができる。特に乳酸カルシウムを添加する場合など、添加するカルシウム化合物が大豆蛋白溶液のpHを中性から酸性側へシフトさせる作用を有する場合に有効である。さらに、キレート剤が酸味を呈するものである場合に酸味を減ずることができ、風味を良好にする利点がある。
pH向上剤としては、一般に使用されているものを使用すればよく、特に炭酸水素ナトリウムを使用することが好ましい。添加量は大豆蛋白溶液中に0.03%以上が好ましい。添加量の上限は特に設定されないが、5%以下でも効果は十分である。(PH improver)
The mineral-enhanced soybean protein solution of the present invention preferably further contains a pH improver (a pH adjuster that shifts the pH to the alkaline side). This makes it possible to obtain a stable solution without aggregation while reducing the amount of chelating agent. This is particularly effective when the calcium compound to be added has the effect of shifting the pH of the soy protein solution from neutral to acidic, such as when calcium lactate is added. Further, when the chelating agent has an acidity, the acidity can be reduced, and there is an advantage of improving the flavor.
What is necessary is just to use what is generally used as a pH improver, and it is preferable to use especially sodium hydrogencarbonate. The addition amount is preferably 0.03% or more in the soybean protein solution. The upper limit of the addition amount is not particularly set, but the effect is sufficient even at 5% or less.
また、カルシウム化合物、キレート剤、pH向上剤以外にも、大豆蛋白溶液の風味の嗜好性や機能性を高めるために、必要な食品原料(果汁、果肉、野菜、糖類、油脂、乳製品、穀粉類、澱粉類、カカオマス、鳥獣魚肉製品等)や食品添加物(ミネラル、ビタミン、増粘安定剤、酸味料、香料等)を適宜使用することができる。 In addition to calcium compounds, chelating agents, and pH improvers, necessary food ingredients (fruit juice, pulp, vegetables, sugars, fats and oils, dairy products, flour, etc.) are required to enhance the taste and functionality of the soy protein solution. , Starches, cacao mass, birds and fish products, etc.) and food additives (minerals, vitamins, thickening stabilizers, acidulants, flavors, etc.) can be used as appropriate.
以上の原料が配合された大豆蛋白溶液は、必ずしも必要ではないがホモゲナイザー等の均質機により均質化することが可能である。均質機のホモ圧は乳化に十分な圧力であれば特に制限することはない。 The soybean protein solution in which the above raw materials are blended is not necessarily required, but can be homogenized by a homogenizer such as a homogenizer. The homogenous pressure of the homogenizer is not particularly limited as long as it is sufficient for emulsification.
本発明のミネラル強化大豆蛋白溶液は必要により殺菌を行うことができ、殺菌による加熱処理を経ても大豆蛋白質とカルシウム化合物との反応による凝集は生じにくいのが特徴である。殺菌方法は、特に制限されないが、例えば、原料液に高温高圧水もしくは高圧水蒸気を注入するか、または原料液に対し通電によるジュール加熱、高周波(マイクロ波)による加熱などの直接加熱法や、電磁誘導加熱、電気炉、直火、流動砂浴、溶融塩浴などの間接加熱法を単独でまたは組み合わせる方法が挙げられる。 The mineral-enhanced soy protein solution of the present invention can be sterilized if necessary, and is characterized by hardly causing aggregation due to the reaction between the soy protein and the calcium compound even after heat treatment by sterilization. The sterilization method is not particularly limited. For example, direct heating methods such as injecting high-temperature high-pressure water or high-pressure steam into the raw material liquid, or Joule heating by energizing the raw material liquid, heating by high frequency (microwave), electromagnetic Indirect heating methods such as induction heating, electric furnace, direct fire, fluidized sand bath, molten salt bath and the like may be used alone or in combination.
(成分の定量)
なお、本発明の液状組成物中の大豆蛋白質の定量は、蛋白質が大豆蛋白質のみである場合はケルダール法により行うが、大豆蛋白質以外の蛋白質を含む場合には、ELISA法により測定し、例えば、Pepnel社のSoya protein assay kit等を利用できる。
β−コングリシニンとグリシニンの定量は、大豆蛋白質以外の蛋白質を含まない場合にはSDS-ポリアクリルアミド電気泳動法によって行うことができる。Laemmli( Nature, 227, 680, 1970 )の方法に基づき、ゲル濃度10〜20%のグラジエントゲルで分析し、クマシーブリリアントブルーにて染色した後、得られた泳動パターンをデンシトメーターで測定し、その全体に対する該当画分の面積比率を純度とする。β−コングリシニン含量はα,α’,βサブユニットの総量とし、グリシニン含量は酸性ポリペプチド(A)と塩基性ポリペプチド(B)の総量とすることにより算出することができる。
ただし、大豆蛋白質以外の蛋白質を含む場合には上記の定量法を用いることができないため、J Agric Food Chem, 35, 200-205, 1987.に記載した方法等により精製したβ−コングリシニンとグリシニンについて、J Nutri Sci Vitaminol, 51, 34-39, 2005に記載の方法でポリクローナル抗体を作成し、これらを用いたELISA法により測定することができる。(Quantification of ingredients)
The quantification of the soy protein in the liquid composition of the present invention is performed by the Kjeldahl method when the protein is only soy protein, but when the protein contains a protein other than soy protein, it is measured by the ELISA method, for example, Pepnel's Soya protein assay kit can be used.
β-conglycinin and glycinin can be quantified by SDS-polyacrylamide electrophoresis when proteins other than soybean protein are not included. Based on the method of Laemmli (Nature, 227, 680, 1970), analyzed with a gradient gel having a gel concentration of 10 to 20%, stained with Coomassie Brilliant Blue, and then measured the migration pattern obtained with a densitometer, The area ratio of the corresponding fraction to the whole is defined as purity. The β-conglycinin content can be calculated by the total amount of α, α ′, β subunits, and the glycinin content can be calculated by the total amount of acidic polypeptide (A) and basic polypeptide (B).
However, since the above quantification method cannot be used when proteins other than soybean protein are included, β-conglycinin and glycinin purified by the method described in J Agric Food Chem, 35, 200-205, 1987. Polynuclear antibodies can be prepared by the method described in J Nutri Sci Vitaminol, 51, 34-39, 2005, and assayed by ELISA using these antibodies.
以下、本発明の実施例を示し、本発明の技術思想をより具体的に説明する。 Hereinafter, examples of the present invention will be shown, and the technical idea of the present invention will be described more specifically.
(実施例1)
大豆蛋白素材として、蛋白質あたりのグリシニン含量がそれぞれ0%、20%及び40%である豆乳A(固形分9%、粗蛋白質3.4%)、豆乳B(固形分9%、粗蛋白質4.1%)及び豆乳C(固形分9%、粗蛋白質4.7%)を調製した。次に、各豆乳A〜Cを80部に対して、豆乳中のカルシウム含量が表1の所定量となるように、カルシウム剤として乳酸カルシウム(カルシウム29%含有)を添加し、全量で100部となるように水を配合し、十分に混合した後、レトルト殺菌(121℃、30分)を行い、豆乳の凝集の有無について調べた。Example 1
As soy protein materials, soybean milk A (solid content 9%, crude protein 3.4%), soy milk B (solid content 9%, crude protein 4.1%) and glycinin content per protein of 0%, 20% and 40%, respectively Soymilk C (solid content 9%, crude protein 4.7%) was prepared. Next, with respect to 80 parts of each soy milk A to C, calcium lactate (containing 29% calcium) is added as a calcium agent so that the calcium content in the soy milk becomes a predetermined amount shown in Table 1, and 100 parts in total. Water was blended so that the mixture was sufficiently mixed, and then retort sterilization (121 ° C., 30 minutes) was performed to examine the presence or absence of aggregation of soy milk.
(表1)
(Table 1)
表1の結果の通り、豆乳中の大豆蛋白質中のグリシニン含量が低いほど、乳酸カルシウムを多く、凝集なく添加することが可能であった。豆乳Aは通常のグリシニンが低減されていない豆乳であるため、豆乳中のカルシウム含量が50mgのときも凝集が発生した。 As shown in Table 1, the lower the glycinin content in the soy protein in soymilk, the more calcium lactate was added and it was possible to add without aggregation. Since soy milk A is normal soy milk in which glycinin is not reduced, aggregation occurred even when the calcium content in the soy milk was 50 mg.
(実施例2)
グリシニン欠失大豆から豆乳(固形分9%、粗蛋白質3.4%)を調製し、この豆乳80部に対して、豆乳中のカルシウム含量が60mg/100gとなるようにカルシウム剤として乳酸カルシウム(カルシウム29%含有)、炭酸カルシウム(カルシウム40%含有)又は第三リン酸カルシウム(カルシウム39%含有)を添加し、全量で100部となるように水を配合し、十分に混合した後、レトルト殺菌(121℃、30分)を行い、豆乳が凝集しているか調べた。(Example 2)
Soy milk (solid content 9%, crude protein 3.4%) was prepared from glycinin-deficient soybeans, and calcium lactate (calcium 29) was added to 80 parts of this soy milk so that the calcium content in the soy milk would be 60 mg / 100 g. %)), Calcium carbonate (containing 40% calcium) or tribasic calcium phosphate (containing 39% calcium), blending water so that the total amount becomes 100 parts, thoroughly mixing, then retort sterilization (121 ° C , 30 minutes), and examined whether the soy milk was agglomerated.
(表2)
(Table 2)
表2の結果の通り、グリシニン含量が低い豆乳の場合、カルシウム剤の種類に係わらず、カルシウムを多量に添加できた。特に、水易溶性である乳酸カルシウムを用いても凝集の発生を抑えることができた。 As shown in Table 2, in the case of soy milk having a low glycinin content, a large amount of calcium could be added regardless of the type of calcium preparation. In particular, even when calcium lactate, which is easily soluble in water, was used, the occurrence of aggregation could be suppressed.
(実施例3) −カルボン酸のアルカリ金属塩の添加−
グリシニン欠失大豆から豆乳(固形分9%、粗蛋白質3.4%)を調製し、この豆乳80部に対して、牛乳並みにカルシウムを含有させる(豆乳100gあたりのカルシウム量を100mg)ために乳酸カルシウム0.65部と、表3の各種添加量にてクエン酸ナトリウムを添加し、全量で100部となるように水を配合し、十分に混合した後、レトルト殺菌(121℃、30分)を行い、豆乳が凝集しているか調べた。(Example 3) -Addition of alkali metal salt of carboxylic acid-
Soy milk (solid content 9%, crude protein 3.4%) was prepared from glycinin-deficient soybean, and calcium lactate was added to 80 parts of this soy milk in the same manner as milk (calcium amount per 100 g of soy milk was 100 mg). Add sodium citrate at 0.65 parts and various addition amounts shown in Table 3, mix water so that the total amount becomes 100 parts, thoroughly mix, and then perform retort sterilization (121 ° C, 30 minutes), It was investigated whether the soymilk was agglomerated.
(表3)
(Table 3)
表3の結果の通り、0.3%以上のクエン酸ナトリウムを添加することにより、牛乳並み(100mg/100g)のカルシウムを含有していても凝集しない豆乳を調製することができた。 As shown in Table 3, by adding 0.3% or more of sodium citrate, a soy milk that does not flocculate even if it contains calcium equivalent to milk (100 mg / 100 g) could be prepared.
(実施例4)
グリシニン欠失大豆から豆乳(固形分9%、粗蛋白質3.4%)を調製し、この豆乳80部に対して、牛乳並みにカルシウムを含有させる(豆乳100gあたりのカルシウム量を100mg)ために乳酸カルシウム0.65部、クエン酸ナトリウム0.3部、水19.05部の配合で調合し、超高温瞬間殺菌(144℃、4秒)を行い、豆乳が凝集しているか調べた。その結果、レトルト殺菌の場合と同様に超高温瞬間殺菌を行っても凝集は確認されなかった。Example 4
Soy milk (solid content 9%, crude protein 3.4%) was prepared from glycinin-deficient soybean, and calcium lactate was added to 80 parts of this soy milk in the same manner as milk (calcium amount per 100 g of soy milk was 100 mg). A mixture of 0.65 parts, 0.3 parts of sodium citrate, and 19.05 parts of water was prepared and subjected to ultra-high temperature instant sterilization (144 ° C., 4 seconds) to check whether the soy milk was aggregated. As a result, agglomeration was not confirmed even when ultra-high temperature instant sterilization was performed as in the case of retort sterilization.
(実施例5) −炭酸水素ナトリウムの添加−
グリシニン欠失大豆から豆乳(固形分9%、粗蛋白質3.4%)を調製し、この豆乳80部に対して、牛乳並みにカルシウムを含有させる(豆乳100gあたりのカルシウム量を100mg)ために乳酸カルシウム0.65部、クエン酸ナトリウム0.15部、炭酸水素ナトリウム0.05部、水19.15部の配合で調合し、レトルト殺菌(140℃、30分)を行い、豆乳が凝集しているか調べた。また、比較実施例として、実施例3において凝集が確認されなかった配合(乳酸カルシウム0.65部、クエン酸ナトリウム 0.3部)を挙げた。(Example 5) -Addition of sodium bicarbonate-
Soy milk (solid content 9%, crude protein 3.4%) was prepared from glycinin-deficient soybean, and calcium lactate was added to 80 parts of this soy milk in the same manner as milk (calcium amount per 100 g of soy milk was 100 mg). A mixture of 0.65 parts, sodium citrate 0.15 parts, sodium hydrogen carbonate 0.05 parts, and water 19.15 parts was prepared and subjected to retort sterilization (140 ° C., 30 minutes) to examine whether the soy milk was agglomerated. Further, as a comparative example, a formulation (0.65 part calcium lactate, 0.3 part sodium citrate) in which aggregation was not confirmed in Example 3 was cited.
(表4)
(Table 4)
その結果、表4の通り、炭酸水素ナトリウムをクエン酸ナトリウムと併用してpHを向上させることにより、クエン酸ナトリウムの添加量が0.3%未満において牛乳並み(100mg/100g)のカルシウムを含有する安定な豆乳を調製することができた。また、比較実施例と風味を比較した場合、実施例5の方が酸味が少なく、飲みやすいという評価であった(5/5名)。 As a result, as shown in Table 4, sodium bicarbonate is used in combination with sodium citrate to improve pH, so that the amount of sodium citrate added is less than 0.3% and contains calcium equivalent to milk (100 mg / 100 g). A stable soymilk could be prepared. Moreover, when comparing the flavor with the comparative example, it was evaluated that Example 5 had less sourness and was easier to drink (5/5 persons).
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008070903 | 2008-03-19 | ||
JP2008070903 | 2008-03-19 | ||
PCT/JP2009/055481 WO2009116636A1 (en) | 2008-03-19 | 2009-03-19 | Mineral-enriched soybean protein solution |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2009116636A1 true JPWO2009116636A1 (en) | 2011-07-21 |
Family
ID=41091034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010503933A Pending JPWO2009116636A1 (en) | 2008-03-19 | 2009-03-19 | Mineral fortified soy protein solution |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2009116636A1 (en) |
WO (1) | WO2009116636A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10736342B2 (en) | 2016-03-03 | 2020-08-11 | General Mills, Inc. | Aseptic protein beverage and method of preparation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5290662A (en) * | 1976-01-19 | 1977-07-30 | Harushichi Iwashita | Method of producing soybean milk rich in calcium |
JPH1156250A (en) * | 1997-08-27 | 1999-03-02 | Fuji Oil Co Ltd | Protein degradation product and its production |
JP3864712B2 (en) * | 2001-03-08 | 2007-01-10 | 不二製油株式会社 | Protein drink |
JP3889358B2 (en) * | 2002-12-27 | 2007-03-07 | 三栄源エフ・エフ・アイ株式会社 | Method for producing calcium-enriched soymilk beverage |
-
2009
- 2009-03-19 WO PCT/JP2009/055481 patent/WO2009116636A1/en active Application Filing
- 2009-03-19 JP JP2010503933A patent/JPWO2009116636A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2009116636A1 (en) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103478254B (en) | High calcium milk and feedstock composition thereof and preparation method | |
WO2000008943A1 (en) | Process for producing soy milk | |
CN106819125A (en) | Dairy products and preparation method thereof | |
Kaharso et al. | Quality improvement of soymilk as influenced by anaerobic grinding method and calcium addition | |
KR100839082B1 (en) | Manufacturing method of bean-curd to use coagulator of magnesium chloride | |
CN105707285A (en) | Method for improving stability of sour whey protein beverage | |
JP6433475B2 (en) | Method for suppressing burning of fluid nutritional composition containing L-arginine | |
JP2008283900A (en) | Dispersion stabilizer of soymilk | |
CN103609702A (en) | High-stability acid modified milk and preparation method thereof | |
JP5402921B2 (en) | Concentrated liquid food containing soy protein | |
JP4185048B2 (en) | Bean raw material beverage and method for producing solid fermented food | |
JPWO2009116636A1 (en) | Mineral fortified soy protein solution | |
CN103859051B (en) | A kind of fruit juice soymilk and preparation method thereof | |
WO2022054879A1 (en) | Tofu production method | |
JP2008022824A (en) | Soybean cream-like food, and method for producing the same | |
Zhang et al. | Replacing animal proteins with plant proteins: Is this a way to improve quality and functional properties of hybrid cheeses and cheese analogs? | |
JP2021090412A (en) | Unpleasant taste masking agent, acidic protein beverage, unpleasant taste masking method, and method for producing acidic protein beverage | |
JP2006340612A (en) | Composition for enriching mineral | |
JP2010120906A (en) | Liquid state emulsified nutritive composition | |
US7923051B2 (en) | Method for the manufacturing of a soy protein-based preparation | |
JP2006238811A (en) | Brown rice-containing soybean curd and method for producing the same | |
CN115444035B (en) | Goat milk coffee mate | |
JP6565260B2 (en) | Soy protein-containing liquid food and drink and method for producing the same | |
JP2006061139A (en) | Method for producing acidic soybean protein-containing beverage | |
JP7271582B2 (en) | Low-calorie soymilk with reduced bean odor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120305 |
|
A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20130716 |